Tech takes VC so start-ups look to BIRAC as Indian 'messiah'
This article was originally published in Scrip
Executive Summary
With venture capital funds (VCs) behaving almost like bankers when it comes to investing in Indian biotech, the government has emerged as the new "messiah" for start-ups in the sector, according to Dr P M Murali, president of the Association of Biotechnology Led Enterprises (ABLE) and managing director and CEO of Evolva Biotech.